Back to Search Start Over

Recommendations on the management of multiple myeloma in 2020

Authors :
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - (SLuc) Centre du cancer
UCL - (SLuc) Service d'hématologie
Vekemans, Marie-Christiane
Doyen, Chantal
Caers, Jo
Wu, Kalung
Kentos, Alain
Mineur, Philippe
Michaux, Lucienne
Delforge, Michel
Meuleman, Nathalie
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - (SLuc) Centre du cancer
UCL - (SLuc) Service d'hématologie
Vekemans, Marie-Christiane
Doyen, Chantal
Caers, Jo
Wu, Kalung
Kentos, Alain
Mineur, Philippe
Michaux, Lucienne
Delforge, Michel
Meuleman, Nathalie
Source :
Acta Clinica Belgica, Vol. 77, no.2, p. 445-461 (2020)
Publication Year :
2022

Abstract

The landscape of treatment in multiple myeloma (MM) is rapidly changing. Based on an extensive review of the recent literature, we propose an update of our recommendations on myeloma care [1], to be used by Belgian hematologists as a reference for daily practice. Levels of evidence and grades of recommendations are based on previously published methods [2]. We recommend participation in clinical trials to gain knowledge in the fast-evolving field of MM treatment.

Details

Database :
OAIster
Journal :
Acta Clinica Belgica, Vol. 77, no.2, p. 445-461 (2020)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1372954381
Document Type :
Electronic Resource